A Decade of Partnership and Impact
Turning Scientific Insight into New Medicines

This year marks the 10th anniversary of the Center for Drug Discovery (CDD), and all faculty, staff, and trainees are invited to join in celebrating this milestone. The scientific symposium will highlight discoveries and innovations made possible through CDD collaboration and support across WashU.

Featured speakers:

• Doug Frantz, PhD
  Catalyzing a New Era in Drug Discovery at WashU

• Aaron Di Antonio, MD, PhD
  Drugging the SARM1 Axon Degeneration Pathway: A Second Bite at the Apple

• Mark Rutherford, PhD
  Subtype-Selective AMPA Receptor Antagonists for Hyperexcitability Disorders

• Priyanka Verma, PhD
  Targeting ALC1 ATPase Activity as a New Synthetic Lethal Strategy in BRCA-Mutant Cancers

• Maggie Chen, MD, PhD
  Developing Molecular Therapeutics for Genetic Kidney Disease

• Jeffrey Millman, PhD
  Diabetes Cell Replacement Therapy using Stem Cell-Derived Islets

• Jim Janetka, PhD
  Harnessing Inhibitors of Kinases for Parasitic Diseases

Register here to attend and to reserve your spot for lunch.

For more information, please see the event website.

Questions?

Please contact Ron Dolle at rdolle@wustl.edu.

Established in 2016, the CDD offers a full suite of preclinical drug discovery services and know-how. Capabilities range from drug lead finding utilizing the High Throughput Screening Core to Medicinal Chemistry-driven drug lead optimization, ADME profiling, and in vivo pharmacokinetics. Please visit the CDD website for more information and funding opportunities.